Login

We are 40! Talks at DFI - Steven Tsai, President of DFI Inc | Steven Tsai, CEO, DFI Inc2397:TAI 00:10:00

Share On Facebook Share On Twitter

Currently, Steven Tsai is the President of DFI Inc.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Tanner Growth Financial Advisors: Mid-Year Review on Market Resilience and Economic Trends
00:10:00
ADVFN - Caspian Sunrise CEO interview | Kuat Rafikuly Oraziman, CEO, Caspian Sunrise PLCCASP:LSE
00:10:00
Phunware Inc. Chief Operating Officer Randall Crowder shares news of the company licensing its technology with Proactive's Stephen Gunnion..|Mike Snavely is Chief Executive Officer & Director of Phunware
00:10:00
C. Vann Woodward: America's Historian and His Influence|James Cobb,Professor,University of Georgia
00:10:00
ABGSC Investor Day - DistIT | Per Kaufmann ,CEO of Distit ab
00:10:00
Searchlight Resources' Uranium and Rare Earth Potential in the Wallaston Domain
00:10:00
Michael Watson: Reflections on Politics and Activism|Michael Walzer,Professor,Institute for Advanced Studies
00:10:00
Pioneering Investments: U.S. Involvement in China's Booming Tech Economy|Hans Tung,Investor, Notable Capital
00:10:00
Optimizing Your 401k: RAM Services Explained - Finance Moment Podcast | Jason Gunkel - Chief Investment Officer, Financial Planner of Syverson Strege
00:10:00
AXA IM Research Award 2022: Supporting Professor Ana Queiros' Research in Blue Carbon
00:10:00
Enhanced EDS Analysis with Flat Quad Detector Revolutionizes Complex Sample Measurement
00:10:00
New Year Tips with Susan Zimmerman | Susan Zimmerman - Co-Founder and Program Director of Mindful Asset Planning

© 2017 - Neuhu+